Private Advisor »

Context Therapeutics shares owned by Private Advisor

Quarter-by-quarter ownership of Context Therapeutics (CNTX) shares owned by Private Advisor from 13F filings

Historical chart of Private Advisor investment in Context Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Context Therapeutics held by Private Advisor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Context Therapeutics by Private Advisor

Quarter filed Position value Share count Share price at filing
2026-06-30 $70k 126k 0.55

More positions owned by Private Advisor

Apple (AAPL)
Spdr Series Trust St Str P500etf (SPYM)
NVIDIA Corporation (NVDA)
Vanguard Index Fds Total Stk Mkt (VTI)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
Spdr Series Trust ST STR P500GRW (SPYG)
Capital Group Dividend Value Shs Creat Unit (CGDV)
First Tr Exchange Traded Risng Divd Achiv (RDVY)
Amazon (AMZN)
Spdr Series Trust ST STR PR SP1500 (SPTM)
Microsoft Corporation (MSFT)
J P Morgan Exchange Traded F Active Bond Etf (JBND)
Select Sector Spdr Tr St Str Techn Etf (XLK)

View all positions for Private Advisor

Top funds holding Context Therapeutics

Nextech Invest
Deep Track Capital
Soleus Capital Management
BlackRock
Avidity Partners Management
Franklin Resources
Vanguard Capital Management
Octagon Capital Advisors
Blue Owl Capital Holdings
TCG Crossover Management
Geode Capital Management
MPM Oncology Impact Management
Renaissance Technologies
Acadian Asset Management
ADAR1 Capital Management

View all funds holding Context Therapeutics